APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pediatric Drugs and Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pediatric Drugs and Vaccines Market Analysis and Forecast 2026-2032

20 December 2025204 pages

Choose your research edition.

Industry ResearchPediatric Drugs and Vaccines Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Pediatric Drugs and Vaccines Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Pediatric Drugs and Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pediatric Drugs and Vaccines Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Pediatric Drugs and Vaccines Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Pediatric Drugs and Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pediatric Drugs and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pediatric Drugs and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pediatric Drugs and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pediatric Drugs and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pediatric Drugs and Vaccines include Janssen Biologics B.V. (USA), Takeda, Sanofi S.A (France), Novartis AG (Switzerland), Novo Nordisk A/S (Denmark), Merck & Co., Inc. (USA), Eli Lilly and Company (USA), Pfizer, Inc. (USA) and GlaxoSmithKline plc. (UK), etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pediatric Drugs and Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pediatric Drugs and Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Pediatric Drugs and Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pediatric Drugs and Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pediatric Drugs and Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pediatric Drugs and Vaccines sales, projected growth trends, production technology, application and end-user industry.

Pediatric Drugs and Vaccines Segment by Company

Janssen Biologics B.V. (USA)

Takeda

Sanofi S.A (France)

Novartis AG (Switzerland)

Novo Nordisk A/S (Denmark)

Merck & Co., Inc. (USA)

Eli Lilly and Company (USA)

Pfizer, Inc. (USA)

GlaxoSmithKline plc. (UK)

Amgen, Inc. (USA)

Shionogi Inc. (USA)

Genentech, Inc. (USA)

F. Hoffmann-La Roche Ltd (Switzerland)

Bristol-Myers Squibb Company (USA)

Boehringer Ingelheim GmbH (Germany)

AstraZeneca Plc. (UK)

Allergan, Inc. (USA)

Actelion Pharmaceuticals

Abbott Laboratories (USA)

Pediatric Drugs and Vaccines Segment by Type

Diphtheria

Pneumococcal Diseases

Hepatitis

Influenza

Mumps

Meningococcal Diseases

Others

Pediatric Drugs and Vaccines Segment by Application

Child

Newborn

Infant

Pediatric Drugs and Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pediatric Drugs and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pediatric Drugs and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pediatric Drugs and Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pediatric Drugs and Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pediatric Drugs and Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pediatric Drugs and Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pediatric Drugs and Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Diphtheria Major Manufacturers Table 3. Pneumococcal Diseases Major Manufacturers Table 4. Hepatitis Major Manufacturers Table 5. Influenza Major Manufacturers Table 6. Mumps Major Manufacturers Table 7. Meningococcal Diseases Major Manufacturers Table 8. Others Major Manufacturers Table 9. Global Pediatric Drugs and Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 10. Child Major Manufacturers Table 11. Newborn Major Manufacturers Table 12. Infant Major Manufacturers Table 13. Pediatric Drugs and Vaccines Industry Trends Table 14. Pediatric Drugs and Vaccines Industry Drivers Table 15. Pediatric Drugs and Vaccines Industry Opportunities and Challenges Table 16. Pediatric Drugs and Vaccines Industry Restraints Table 17. Global Pediatric Drugs and Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Pediatric Drugs and Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Pediatric Drugs and Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Pediatric Drugs and Vaccines Revenue Market Share by Region (2021-2026) Table 21. Global Pediatric Drugs and Vaccines Revenue Market Share by Region (2027-2032) Table 22. Global Pediatric Drugs and Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 23. Global Pediatric Drugs and Vaccines Sales by Region (2021-2026) & (K Units) Table 24. Global Pediatric Drugs and Vaccines Sales by Region (2027-2032) & (K Units) Table 25. Global Pediatric Drugs and Vaccines Sales Market Share by Region (2021-2026) Table 26. Global Pediatric Drugs and Vaccines Sales Market Share by Region (2027-2032) Table 27. Global Pediatric Drugs and Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Pediatric Drugs and Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Pediatric Drugs and Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Pediatric Drugs and Vaccines Sales Market Share by Manufacturers (2021-2026) Table 31. Global Pediatric Drugs and Vaccines Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Pediatric Drugs and Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Pediatric Drugs and Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Pediatric Drugs and Vaccines Manufacturers, Product Type & Application Table 35. Global Pediatric Drugs and Vaccines Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Pediatric Drugs and Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Pediatric Drugs and Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Pediatric Drugs and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Pediatric Drugs and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2021-2026) Table 42. Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2027-2032) Table 43. Global Pediatric Drugs and Vaccines Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 44. Global Pediatric Drugs and Vaccines Sales by Type (2021-2026) & (K Units) Table 45. Global Pediatric Drugs and Vaccines Sales by Type (2027-2032) & (K Units) Table 46. Global Pediatric Drugs and Vaccines Sales Market Share by Type (2021-2026) Table 47. Global Pediatric Drugs and Vaccines Sales Market Share by Type (2027-2032) Table 48. Global Pediatric Drugs and Vaccines Price by Type (2021-2026) & (US$/Unit) Table 49. Global Pediatric Drugs and Vaccines Price by Type (2027-2032) & (US$/Unit) Table 50. Global Pediatric Drugs and Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Pediatric Drugs and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Pediatric Drugs and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2021-2026) Table 54. Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2027-2032) Table 55. Global Pediatric Drugs and Vaccines Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 56. Global Pediatric Drugs and Vaccines Sales by Application (2021-2026) & (K Units) Table 57. Global Pediatric Drugs and Vaccines Sales by Application (2027-2032) & (K Units) Table 58. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2021-2026) Table 59. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2027-2032) Table 60. Global Pediatric Drugs and Vaccines Price by Application (2021-2026) & (US$/Unit) Table 61. Global Pediatric Drugs and Vaccines Price by Application (2027-2032) & (US$/Unit) Table 62. Janssen Biologics B.V. (USA) Company Information Table 63. Janssen Biologics B.V. (USA) Business Overview Table 64. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Portfolio Table 66. Janssen Biologics B.V. (USA) Recent Development Table 67. Takeda Company Information Table 68. Takeda Business Overview Table 69. Takeda Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Takeda Pediatric Drugs and Vaccines Product Portfolio Table 71. Takeda Recent Development Table 72. Sanofi S.A (France) Company Information Table 73. Sanofi S.A (France) Business Overview Table 74. Sanofi S.A (France) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Sanofi S.A (France) Pediatric Drugs and Vaccines Product Portfolio Table 76. Sanofi S.A (France) Recent Development Table 77. Novartis AG (Switzerland) Company Information Table 78. Novartis AG (Switzerland) Business Overview Table 79. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Portfolio Table 81. Novartis AG (Switzerland) Recent Development Table 82. Novo Nordisk A/S (Denmark) Company Information Table 83. Novo Nordisk A/S (Denmark) Business Overview Table 84. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Portfolio Table 86. Novo Nordisk A/S (Denmark) Recent Development Table 87. Merck & Co., Inc. (USA) Company Information Table 88. Merck & Co., Inc. (USA) Business Overview Table 89. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio Table 91. Merck & Co., Inc. (USA) Recent Development Table 92. Eli Lilly and Company (USA) Company Information Table 93. Eli Lilly and Company (USA) Business Overview Table 94. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Portfolio Table 96. Eli Lilly and Company (USA) Recent Development Table 97. Pfizer, Inc. (USA) Company Information Table 98. Pfizer, Inc. (USA) Business Overview Table 99. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio Table 101. Pfizer, Inc. (USA) Recent Development Table 102. GlaxoSmithKline plc. (UK) Company Information Table 103. GlaxoSmithKline plc. (UK) Business Overview Table 104. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Portfolio Table 106. GlaxoSmithKline plc. (UK) Recent Development Table 107. Amgen, Inc. (USA) Company Information Table 108. Amgen, Inc. (USA) Business Overview Table 109. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio Table 111. Amgen, Inc. (USA) Recent Development Table 112. Shionogi Inc. (USA) Company Information Table 113. Shionogi Inc. (USA) Business Overview Table 114. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio Table 116. Shionogi Inc. (USA) Recent Development Table 117. Genentech, Inc. (USA) Company Information Table 118. Genentech, Inc. (USA) Business Overview Table 119. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio Table 121. Genentech, Inc. (USA) Recent Development Table 122. F. Hoffmann-La Roche Ltd (Switzerland) Company Information Table 123. F. Hoffmann-La Roche Ltd (Switzerland) Business Overview Table 124. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Portfolio Table 126. F. Hoffmann-La Roche Ltd (Switzerland) Recent Development Table 127. Bristol-Myers Squibb Company (USA) Company Information Table 128. Bristol-Myers Squibb Company (USA) Business Overview Table 129. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Portfolio Table 131. Bristol-Myers Squibb Company (USA) Recent Development Table 132. Boehringer Ingelheim GmbH (Germany) Company Information Table 133. Boehringer Ingelheim GmbH (Germany) Business Overview Table 134. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Portfolio Table 136. Boehringer Ingelheim GmbH (Germany) Recent Development Table 137. AstraZeneca Plc. (UK) Company Information Table 138. AstraZeneca Plc. (UK) Business Overview Table 139. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Portfolio Table 141. AstraZeneca Plc. (UK) Recent Development Table 142. Allergan, Inc. (USA) Company Information Table 143. Allergan, Inc. (USA) Business Overview Table 144. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio Table 146. Allergan, Inc. (USA) Recent Development Table 147. Actelion Pharmaceuticals Company Information Table 148. Actelion Pharmaceuticals Business Overview Table 149. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Portfolio Table 151. Actelion Pharmaceuticals Recent Development Table 152. Abbott Laboratories (USA) Company Information Table 153. Abbott Laboratories (USA) Business Overview Table 154. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Portfolio Table 156. Abbott Laboratories (USA) Recent Development Table 157. North America Pediatric Drugs and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 158. North America Pediatric Drugs and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 159. North America Pediatric Drugs and Vaccines Sales by Type (2021-2026) & (K Units) Table 160. North America Pediatric Drugs and Vaccines Sales by Type (2027-2032) & (K Units) Table 161. North America Pediatric Drugs and Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 162. North America Pediatric Drugs and Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 163. North America Pediatric Drugs and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 164. North America Pediatric Drugs and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 165. North America Pediatric Drugs and Vaccines Sales by Application (2021-2026) & (K Units) Table 166. North America Pediatric Drugs and Vaccines Sales by Application (2027-2032) & (K Units) Table 167. North America Pediatric Drugs and Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 168. North America Pediatric Drugs and Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 169. North America Pediatric Drugs and Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. North America Pediatric Drugs and Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. North America Pediatric Drugs and Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. North America Pediatric Drugs and Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 173. North America Pediatric Drugs and Vaccines Sales by Country (2021-2026) & (K Units) Table 174. North America Pediatric Drugs and Vaccines Sales by Country (2027-2032) & (K Units) Table 175. North America Pediatric Drugs and Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 176. North America Pediatric Drugs and Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 177. United States Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 178. Canada Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 179. Europe Pediatric Drugs and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 180. Europe Pediatric Drugs and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 181. Europe Pediatric Drugs and Vaccines Sales by Type (2021-2026) & (K Units) Table 182. Europe Pediatric Drugs and Vaccines Sales by Type (2027-2032) & (K Units) Table 183. Europe Pediatric Drugs and Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 184. Europe Pediatric Drugs and Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 185. Europe Pediatric Drugs and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 186. Europe Pediatric Drugs and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 187. Europe Pediatric Drugs and Vaccines Sales by Application (2021-2026) & (K Units) Table 188. Europe Pediatric Drugs and Vaccines Sales by Application (2027-2032) & (K Units) Table 189. Europe Pediatric Drugs and Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 190. Europe Pediatric Drugs and Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 191. Europe Pediatric Drugs and Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 192. Europe Pediatric Drugs and Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 193. Europe Pediatric Drugs and Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 194. Europe Pediatric Drugs and Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 195. Europe Pediatric Drugs and Vaccines Sales by Country (2021-2026) & (K Units) Table 196. Europe Pediatric Drugs and Vaccines Sales by Country (2027-2032) & (K Units) Table 197. Europe Pediatric Drugs and Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 198. Europe Pediatric Drugs and Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 199. Germany Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 200. France Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 201. U.K. Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 202. Italy Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 203. Netherlands Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 204. China Pediatric Drugs and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 205. China Pediatric Drugs and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 206. China Pediatric Drugs and Vaccines Sales by Type (2021-2026) & (K Units) Table 207. China Pediatric Drugs and Vaccines Sales by Type (2027-2032) & (K Units) Table 208. China Pediatric Drugs and Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 209. China Pediatric Drugs and Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 210. China Pediatric Drugs and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 211. China Pediatric Drugs and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 212. China Pediatric Drugs and Vaccines Sales by Application (2021-2026) & (K Units) Table 213. China Pediatric Drugs and Vaccines Sales by Application (2027-2032) & (K Units) Table 214. China Pediatric Drugs and Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 215. China Pediatric Drugs and Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 216. Asia Pediatric Drugs and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 217. Asia Pediatric Drugs and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 218. Asia Pediatric Drugs and Vaccines Sales by Type (2021-2026) & (K Units) Table 219. Asia Pediatric Drugs and Vaccines Sales by Type (2027-2032) & (K Units) Table 220. Asia Pediatric Drugs and Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 221. Asia Pediatric Drugs and Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 222. Asia Pediatric Drugs and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 223. Asia Pediatric Drugs and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 224. Asia Pediatric Drugs and Vaccines Sales by Application (2021-2026) & (K Units) Table 225. Asia Pediatric Drugs and Vaccines Sales by Application (2027-2032) & (K Units) Table 226. Asia Pediatric Drugs and Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 227. Asia Pediatric Drugs and Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 228. Asia Pediatric Drugs and Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 229. Asia Pediatric Drugs and Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 230. Asia Pediatric Drugs and Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 231. Asia Pediatric Drugs and Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 232. Asia Pediatric Drugs and Vaccines Sales by Country (2021-2026) & (K Units) Table 233. Asia Pediatric Drugs and Vaccines Sales by Country (2027-2032) & (K Units) Table 234. Asia Pediatric Drugs and Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 235. Asia Pediatric Drugs and Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 236. Japan Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 237. South Korea Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 238. India Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 239. Australia Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 240. China Taiwan Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 241. Southeast Asia Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 242. SAMEA Pediatric Drugs and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 243. SAMEA Pediatric Drugs and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 244. SAMEA Pediatric Drugs and Vaccines Sales by Type (2021-2026) & (K Units) Table 245. SAMEA Pediatric Drugs and Vaccines Sales by Type (2027-2032) & (K Units) Table 246. SAMEA Pediatric Drugs and Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 247. SAMEA Pediatric Drugs and Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 248. SAMEA Pediatric Drugs and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 249. SAMEA Pediatric Drugs and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 250. SAMEA Pediatric Drugs and Vaccines Sales by Application (2021-2026) & (K Units) Table 251. SAMEA Pediatric Drugs and Vaccines Sales by Application (2027-2032) & (K Units) Table 252. SAMEA Pediatric Drugs and Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 253. SAMEA Pediatric Drugs and Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 254. SAMEA Pediatric Drugs and Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 255. SAMEA Pediatric Drugs and Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 256. SAMEA Pediatric Drugs and Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 257. SAMEA Pediatric Drugs and Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 258. SAMEA Pediatric Drugs and Vaccines Sales by Country (2021-2026) & (K Units) Table 259. SAMEA Pediatric Drugs and Vaccines Sales by Country (2027-2032) & (K Units) Table 260. SAMEA Pediatric Drugs and Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 261. SAMEA Pediatric Drugs and Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 262. Brazil Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 263. Argentina Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 264. Chile Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 265. Colombia Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 266. Peru Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 267. Saudi Arabia Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 268. Israel Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 269. UAE Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 270. Turkey Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 271. Iran Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 272. Egypt Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Table 273. Key Raw Materials Table 274. Raw Materials Key Suppliers Table 275. Pediatric Drugs and Vaccines Distributors List Table 276. Pediatric Drugs and Vaccines Customers List Table 277. Research Programs/Design for This Report Table 278. Authors List of This Report Table 279. Secondary Sources Table 280. Primary Sources List of Figures Figure 1. Pediatric Drugs and Vaccines Image Figure 2. Global Pediatric Drugs and Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pediatric Drugs and Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Diphtheria Image Figure 5. Pneumococcal Diseases Image Figure 6. Hepatitis Image Figure 7. Influenza Image Figure 8. Mumps Image Figure 9. Meningococcal Diseases Image Figure 10. Others Image Figure 11. Global Pediatric Drugs and Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Pediatric Drugs and Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 13. Child Image Figure 14. Newborn Image Figure 15. Infant Image Figure 16. Global Pediatric Drugs and Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Pediatric Drugs and Vaccines Revenue (2021-2032) & (US$ Million) Figure 18. Global Pediatric Drugs and Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Pediatric Drugs and Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Pediatric Drugs and Vaccines Revenue Market Share by Region (2021-2032) Figure 21. Global Pediatric Drugs and Vaccines Sales (2021-2032) & (K Units) Figure 22. Global Pediatric Drugs and Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 23. Global Pediatric Drugs and Vaccines Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Pediatric Drugs and Vaccines Sales YoY (2021-2032) & (K Units) Figure 25. Europe Pediatric Drugs and Vaccines Sales YoY (2021-2032) & (K Units) Figure 26. China Pediatric Drugs and Vaccines Sales YoY (2021-2032) & (K Units) Figure 27. Asia (Excluding China) Pediatric Drugs and Vaccines Sales YoY (2021-2032) & (K Units) Figure 28. South America, Middle East and Africa Pediatric Drugs and Vaccines Sales YoY (2021-2032) & (K Units) Figure 29. Global Pediatric Drugs and Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Pediatric Drugs and Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Pediatric Drugs and Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Pediatric Drugs and Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2021-2032) Figure 35. Global Pediatric Drugs and Vaccines Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Pediatric Drugs and Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Pediatric Drugs and Vaccines Sales Market Share by Type (2021-2032) Figure 38. Global Pediatric Drugs and Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Pediatric Drugs and Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2021-2032) Figure 41. Global Pediatric Drugs and Vaccines Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 42. Global Pediatric Drugs and Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2021-2032) Figure 44. North America Pediatric Drugs and Vaccines Revenue Share by Type (2021-2032) Figure 45. North America Pediatric Drugs and Vaccines Sales Share by Type (2021-2032) Figure 46. North America Pediatric Drugs and Vaccines Revenue Share by Application (2021-2032) Figure 47. North America Pediatric Drugs and Vaccines Sales Share by Application (2021-2032) Figure 48. North America Pediatric Drugs and Vaccines Revenue Share by Country (2021-2032) Figure 49. North America Pediatric Drugs and Vaccines Sales Share by Country (2021-2032) Figure 50. Europe Pediatric Drugs and Vaccines Revenue Share by Type (2021-2032) Figure 51. Europe Pediatric Drugs and Vaccines Sales Share by Type (2021-2032) Figure 52. Europe Pediatric Drugs and Vaccines Revenue Share by Application (2021-2032) Figure 53. Europe Pediatric Drugs and Vaccines Sales Share by Application (2021-2032) Figure 54. Europe Pediatric Drugs and Vaccines Revenue Share by Country (2021-2032) Figure 55. Europe Pediatric Drugs and Vaccines Sales Share by Country (2021-2032) Figure 56. China Pediatric Drugs and Vaccines Revenue Share by Type (2021-2032) Figure 57. China Pediatric Drugs and Vaccines Sales Share by Type (2021-2032) Figure 58. China Pediatric Drugs and Vaccines Revenue Share by Application (2021-2032) Figure 59. China Pediatric Drugs and Vaccines Sales Share by Application (2021-2032) Figure 60. Asia Pediatric Drugs and Vaccines Revenue Share by Type (2021-2032) Figure 61. Asia Pediatric Drugs and Vaccines Sales Share by Type (2021-2032) Figure 62. Asia Pediatric Drugs and Vaccines Revenue Share by Application (2021-2032) Figure 63. Asia Pediatric Drugs and Vaccines Sales Share by Application (2021-2032) Figure 64. Asia Pediatric Drugs and Vaccines Revenue Share by Country (2021-2032) Figure 65. Asia Pediatric Drugs and Vaccines Sales Share by Country (2021-2032) Figure 66. SAMEA Pediatric Drugs and Vaccines Revenue Share by Type (2021-2032) Figure 67. SAMEA Pediatric Drugs and Vaccines Sales Share by Type (2021-2032) Figure 68. SAMEA Pediatric Drugs and Vaccines Revenue Share by Application (2021-2032) Figure 69. SAMEA Pediatric Drugs and Vaccines Sales Share by Application (2021-2032) Figure 70. SAMEA Pediatric Drugs and Vaccines Revenue Share by Country (2021-2032) Figure 71. SAMEA Pediatric Drugs and Vaccines Sales Share by Country (2021-2032) Figure 72. Pediatric Drugs and Vaccines Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Pediatric Drugs and Vaccines Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Diphtheria
  • Pneumococcal Diseases
  • Hepatitis
  • Influenza
  • Mumps
  • Meningococcal Diseases
  • Others
Applications
  • Child
  • Newborn
  • Infant
Companies covered
  • Janssen Biologics B.V. (USA)
  • Takeda
  • Sanofi S.A (France)
  • Novartis AG (Switzerland)
  • Novo Nordisk A/S (Denmark)
  • Merck & Co., Inc. (USA)
  • Eli Lilly and Company (USA)
  • Pfizer, Inc. (USA)
  • GlaxoSmithKline plc. (UK)
  • Amgen, Inc. (USA)
  • Shionogi Inc. (USA)
  • Genentech, Inc. (USA)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Bristol-Myers Squibb Company (USA)
  • Boehringer Ingelheim GmbH (Germany)
  • AstraZeneca Plc. (UK)
  • Allergan, Inc. (USA)
  • Actelion Pharmaceuticals
  • Abbott Laboratories (USA)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pediatric Drugs and Vaccines Market by Type
  3. 1.2.1 Global Pediatric Drugs and Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Diphtheria
  5. 1.2.3 Pneumococcal Diseases
  6. 1.2.4 Hepatitis
  7. 1.2.5 Influenza
  8. 1.2.6 Mumps
  9. 1.2.7 Meningococcal Diseases
  10. 1.2.8 Others
  11. 1.3 Pediatric Drugs and Vaccines Market by Application
  12. 1.3.1 Global Pediatric Drugs and Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  13. 1.3.2 Child
  14. 1.3.3 Newborn
  15. 1.3.4 Infant
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Pediatric Drugs and Vaccines Market Dynamics
  1. 2.1 Pediatric Drugs and Vaccines Industry Trends
  2. 2.2 Pediatric Drugs and Vaccines Industry Drivers
  3. 2.3 Pediatric Drugs and Vaccines Industry Opportunities and Challenges
  4. 2.4 Pediatric Drugs and Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pediatric Drugs and Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pediatric Drugs and Vaccines Revenue by Region
  3. 3.2.1 Global Pediatric Drugs and Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pediatric Drugs and Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Pediatric Drugs and Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Pediatric Drugs and Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pediatric Drugs and Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pediatric Drugs and Vaccines Sales by Region
  9. 3.4.1 Global Pediatric Drugs and Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pediatric Drugs and Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Pediatric Drugs and Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Pediatric Drugs and Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pediatric Drugs and Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Pediatric Drugs and Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pediatric Drugs and Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pediatric Drugs and Vaccines Sales by Manufacturers
  6. 4.2.1 Global Pediatric Drugs and Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pediatric Drugs and Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pediatric Drugs and Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pediatric Drugs and Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pediatric Drugs and Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pediatric Drugs and Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pediatric Drugs and Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Pediatric Drugs and Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pediatric Drugs and Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Pediatric Drugs and Vaccines Tier 1, Tier 2, and Tier 3
5 Pediatric Drugs and Vaccines Market by Type
  1. 5.1 Global Pediatric Drugs and Vaccines Revenue by Type
  2. 5.1.1 Global Pediatric Drugs and Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pediatric Drugs and Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pediatric Drugs and Vaccines Sales by Type
  6. 5.2.1 Global Pediatric Drugs and Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pediatric Drugs and Vaccines Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Pediatric Drugs and Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pediatric Drugs and Vaccines Price by Type
6 Pediatric Drugs and Vaccines Market by Application
  1. 6.1 Global Pediatric Drugs and Vaccines Revenue by Application
  2. 6.1.1 Global Pediatric Drugs and Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pediatric Drugs and Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pediatric Drugs and Vaccines Sales by Application
  6. 6.2.1 Global Pediatric Drugs and Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pediatric Drugs and Vaccines Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Pediatric Drugs and Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pediatric Drugs and Vaccines Price by Application
7 Company Profiles
  1. 7.1 Janssen Biologics B.V. (USA)
  2. 7.1.1 Janssen Biologics B.V. (USA) Company Information
  3. 7.1.2 Janssen Biologics B.V. (USA) Business Overview
  4. 7.1.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Portfolio
  6. 7.1.5 Janssen Biologics B.V. (USA) Recent Developments
  7. 7.2 Takeda
  8. 7.2.1 Takeda Company Information
  9. 7.2.2 Takeda Business Overview
  10. 7.2.3 Takeda Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Takeda Pediatric Drugs and Vaccines Product Portfolio
  12. 7.2.5 Takeda Recent Developments
  13. 7.3 Sanofi S.A (France)
  14. 7.3.1 Sanofi S.A (France) Company Information
  15. 7.3.2 Sanofi S.A (France) Business Overview
  16. 7.3.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi S.A (France) Pediatric Drugs and Vaccines Product Portfolio
  18. 7.3.5 Sanofi S.A (France) Recent Developments
  19. 7.4 Novartis AG (Switzerland)
  20. 7.4.1 Novartis AG (Switzerland) Company Information
  21. 7.4.2 Novartis AG (Switzerland) Business Overview
  22. 7.4.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Portfolio
  24. 7.4.5 Novartis AG (Switzerland) Recent Developments
  25. 7.5 Novo Nordisk A/S (Denmark)
  26. 7.5.1 Novo Nordisk A/S (Denmark) Company Information
  27. 7.5.2 Novo Nordisk A/S (Denmark) Business Overview
  28. 7.5.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Portfolio
  30. 7.5.5 Novo Nordisk A/S (Denmark) Recent Developments
  31. 7.6 Merck & Co., Inc. (USA)
  32. 7.6.1 Merck & Co., Inc. (USA) Company Information
  33. 7.6.2 Merck & Co., Inc. (USA) Business Overview
  34. 7.6.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
  36. 7.6.5 Merck & Co., Inc. (USA) Recent Developments
  37. 7.7 Eli Lilly and Company (USA)
  38. 7.7.1 Eli Lilly and Company (USA) Company Information
  39. 7.7.2 Eli Lilly and Company (USA) Business Overview
  40. 7.7.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Portfolio
  42. 7.7.5 Eli Lilly and Company (USA) Recent Developments
  43. 7.8 Pfizer, Inc. (USA)
  44. 7.8.1 Pfizer, Inc. (USA) Company Information
  45. 7.8.2 Pfizer, Inc. (USA) Business Overview
  46. 7.8.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
  48. 7.8.5 Pfizer, Inc. (USA) Recent Developments
  49. 7.9 GlaxoSmithKline plc. (UK)
  50. 7.9.1 GlaxoSmithKline plc. (UK) Company Information
  51. 7.9.2 GlaxoSmithKline plc. (UK) Business Overview
  52. 7.9.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Portfolio
  54. 7.9.5 GlaxoSmithKline plc. (UK) Recent Developments
  55. 7.10 Amgen, Inc. (USA)
  56. 7.10.1 Amgen, Inc. (USA) Company Information
  57. 7.10.2 Amgen, Inc. (USA) Business Overview
  58. 7.10.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
  60. 7.10.5 Amgen, Inc. (USA) Recent Developments
  61. 7.11 Shionogi Inc. (USA)
  62. 7.11.1 Shionogi Inc. (USA) Company Information
  63. 7.11.2 Shionogi Inc. (USA) Business Overview
  64. 7.11.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
  66. 7.11.5 Shionogi Inc. (USA) Recent Developments
  67. 7.12 Genentech, Inc. (USA)
  68. 7.12.1 Genentech, Inc. (USA) Company Information
  69. 7.12.2 Genentech, Inc. (USA) Business Overview
  70. 7.12.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
  72. 7.12.5 Genentech, Inc. (USA) Recent Developments
  73. 7.13 F. Hoffmann-La Roche Ltd (Switzerland)
  74. 7.13.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Information
  75. 7.13.2 F. Hoffmann-La Roche Ltd (Switzerland) Business Overview
  76. 7.13.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Portfolio
  78. 7.13.5 F. Hoffmann-La Roche Ltd (Switzerland) Recent Developments
  79. 7.14 Bristol-Myers Squibb Company (USA)
  80. 7.14.1 Bristol-Myers Squibb Company (USA) Company Information
  81. 7.14.2 Bristol-Myers Squibb Company (USA) Business Overview
  82. 7.14.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Portfolio
  84. 7.14.5 Bristol-Myers Squibb Company (USA) Recent Developments
  85. 7.15 Boehringer Ingelheim GmbH (Germany)
  86. 7.15.1 Boehringer Ingelheim GmbH (Germany) Company Information
  87. 7.15.2 Boehringer Ingelheim GmbH (Germany) Business Overview
  88. 7.15.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Portfolio
  90. 7.15.5 Boehringer Ingelheim GmbH (Germany) Recent Developments
  91. 7.16 AstraZeneca Plc. (UK)
  92. 7.16.1 AstraZeneca Plc. (UK) Company Information
  93. 7.16.2 AstraZeneca Plc. (UK) Business Overview
  94. 7.16.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Portfolio
  96. 7.16.5 AstraZeneca Plc. (UK) Recent Developments
  97. 7.17 Allergan, Inc. (USA)
  98. 7.17.1 Allergan, Inc. (USA) Company Information
  99. 7.17.2 Allergan, Inc. (USA) Business Overview
  100. 7.17.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
  102. 7.17.5 Allergan, Inc. (USA) Recent Developments
  103. 7.18 Actelion Pharmaceuticals
  104. 7.18.1 Actelion Pharmaceuticals Company Information
  105. 7.18.2 Actelion Pharmaceuticals Business Overview
  106. 7.18.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Portfolio
  108. 7.18.5 Actelion Pharmaceuticals Recent Developments
  109. 7.19 Abbott Laboratories (USA)
  110. 7.19.1 Abbott Laboratories (USA) Company Information
  111. 7.19.2 Abbott Laboratories (USA) Business Overview
  112. 7.19.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Portfolio
  114. 7.19.5 Abbott Laboratories (USA) Recent Developments
8 North America
  1. 8.1 North America Pediatric Drugs and Vaccines Market Size by Type
  2. 8.1.1 North America Pediatric Drugs and Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Pediatric Drugs and Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Pediatric Drugs and Vaccines Price by Type (2021-2032)
  5. 8.2 North America Pediatric Drugs and Vaccines Market Size by Application
  6. 8.2.1 North America Pediatric Drugs and Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Pediatric Drugs and Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Pediatric Drugs and Vaccines Price by Application (2021-2032)
  9. 8.3 North America Pediatric Drugs and Vaccines Market Size by Country
  10. 8.3.1 North America Pediatric Drugs and Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pediatric Drugs and Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pediatric Drugs and Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Pediatric Drugs and Vaccines Market Size by Type
  2. 9.1.1 Europe Pediatric Drugs and Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pediatric Drugs and Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Pediatric Drugs and Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Pediatric Drugs and Vaccines Market Size by Application
  6. 9.2.1 Europe Pediatric Drugs and Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pediatric Drugs and Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Pediatric Drugs and Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Pediatric Drugs and Vaccines Market Size by Country
  10. 9.3.1 Europe Pediatric Drugs and Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pediatric Drugs and Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pediatric Drugs and Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Pediatric Drugs and Vaccines Market Size by Type
  2. 10.1.1 China Pediatric Drugs and Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Pediatric Drugs and Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Pediatric Drugs and Vaccines Price by Type (2021-2032)
  5. 10.2 China Pediatric Drugs and Vaccines Market Size by Application
  6. 10.2.1 China Pediatric Drugs and Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Pediatric Drugs and Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Pediatric Drugs and Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pediatric Drugs and Vaccines Market Size by Type
  2. 11.1.1 Asia Pediatric Drugs and Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pediatric Drugs and Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Pediatric Drugs and Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Pediatric Drugs and Vaccines Market Size by Application
  6. 11.2.1 Asia Pediatric Drugs and Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pediatric Drugs and Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Pediatric Drugs and Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Pediatric Drugs and Vaccines Market Size by Country
  10. 11.3.1 Asia Pediatric Drugs and Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pediatric Drugs and Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pediatric Drugs and Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pediatric Drugs and Vaccines Market Size by Type
  2. 12.1.1 SAMEA Pediatric Drugs and Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pediatric Drugs and Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pediatric Drugs and Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Pediatric Drugs and Vaccines Market Size by Application
  6. 12.2.1 SAMEA Pediatric Drugs and Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pediatric Drugs and Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pediatric Drugs and Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Pediatric Drugs and Vaccines Market Size by Country
  10. 12.3.1 SAMEA Pediatric Drugs and Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pediatric Drugs and Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pediatric Drugs and Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pediatric Drugs and Vaccines Value Chain Analysis
  2. 13.1.1 Pediatric Drugs and Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pediatric Drugs and Vaccines Production Mode & Process
  6. 13.2 Pediatric Drugs and Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pediatric Drugs and Vaccines Distributors
  9. 13.2.3 Pediatric Drugs and Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst